| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.11▼ | 1.11▼ | 1.12▼ | 1.20▼ | 1.23▼ |
| MA10 | 1.10▲ | 1.15▼ | 1.16▼ | 1.23▼ | 1.24▼ |
| MA20 | 1.12▼ | 1.23▼ | 1.25▼ | 1.27▼ | 1.28▼ |
| MA50 | 1.27▼ | 1.29▼ | 1.29▼ | 1.27▼ | 1.91▼ |
| MA100 | 1.26▼ | 1.27▼ | 1.27▼ | 1.34▼ | 2.15▼ |
| MA200 | 1.26▼ | 1.27▼ | 1.27▼ | 1.91▼ | 1.82▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.008▲ | -0.013▼ | -0.018▼ | -0.020▼ | 0.026▲ |
| RSI | 34.548▼ | 30.362▼ | 29.845▼ | 34.227▼ | 36.331▼ |
| STOCH | 58.755 | 12.070▼ | 14.284▼ | 2.207▼ | 37.027 |
| WILL %R | -42.824 | -86.762▼ | -88.222▼ | -100.000▼ | -88.657▼ |
| CCI | 24.596 | -74.494 | -81.048 | -155.438▼ | -160.287▼ |
|
Tuesday, April 21, 2026 06:12 AM
Celularity Inc. (Nasdaq: CELU) (“Celularity”), a longevity-focused regenerative and cellular medicine company, today announced the closing of its previously announced transaction with NexGel, Inc.
|
|
Friday, April 17, 2026 01:44 PM
Celularity Inc. (Nasdaq: CELU) (the “Company”), a longevity-focused regenerative and cellular medicine company, today announced that on April 16, 2026, the Company received notification from the ...
|
|
Sunday, January 04, 2026 04:36 AM
Celularity Inc. (Nasdaq: CELU) ("Celularity"), a longevity-focused regenerative and cellular medicine company, today announced the closing of its ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/04/26 | 1.185 | 1.1988 | 1.12 | 1.12 | 75,038 |
| 22/04/26 | 1.23 | 1.25 | 1.17 | 1.17 | 54,535 |
| 21/04/26 | 1.27 | 1.30 | 1.22 | 1.22 | 39,071 |
| 20/04/26 | 1.23 | 1.2779 | 1.22 | 1.24 | 28,780 |
| 17/04/26 | 1.24 | 1.28 | 1.23 | 1.23 | 30,309 |
| 16/04/26 | 1.27 | 1.27 | 1.23 | 1.24 | 29,041 |
| 15/04/26 | 1.2526 | 1.30 | 1.2401 | 1.25 | 5,835 |
| 14/04/26 | 1.3251 | 1.3251 | 1.28 | 1.30 | 8,994 |
| 13/04/26 | 1.30 | 1.32 | 1.2701 | 1.28 | 8,494 |
| 10/04/26 | 1.37 | 1.375 | 1.27 | 1.27 | 11,601 |
|
|
||||
|
|
||||
|
|